Both in Biotechnology
Inhibikase Therapeutics vs Lexeo Therapeutics
Over the past year IKT returned +32.0% and LXEO returned −48.6%; their daily moves had a correlation of 0.26.
IKT +32.0% LXEO −48.6%Growth of $1, one year, split-adjusted
| Metric | IKT | LXEO |
|---|---|---|
| Price | $2.02 | $3.42 |
| Market cap | $281.9M | $280.7M |
| Today | −1.46% | +8.92% |
| 1 month | −16.2% | −29.6% |
| 6 months | +27.8% | −35.1% |
| Year to date | −1.5% | −65.6% |
| 1 year | +30.3% | −49.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $159.0M | $211.1M |
| Dividend yield | — | — |
| Volatility (60d) | 49.7% | 63.4% |
| Short % of float | 17.8% | 28.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).